688617 logo

APT Medical Inc. Stock Price

SHSE:688617 Community·CN¥40.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688617 Share Price Performance

CN¥283.50
49.71 (21.26%)
CN¥283.50
49.71 (21.26%)
Price CN¥283.50

688617 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Exceptional growth potential with flawless balance sheet.

0 Risks
3 Rewards

APT Medical Inc. Key Details

CN¥2.4b

Revenue

CN¥664.1m

Cost of Revenue

CN¥1.7b

Gross Profit

CN¥976.0m

Other Expenses

CN¥768.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Nov 14, 2025
5.45
72.42%
31.90%
0.4%
View Full Analysis

About 688617

Founded
2002
Employees
2915
CEO
Zhenghui Cheng
WebsiteView website
www.aptmed.com

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and accessories. It also provides OEM/ODM service comprising project design and development, customization, and volume OEM for use in catheters, guidewires, delivery systems, nitinol products in cardiology, peripheral, neurology, and urology. APT Medical Inc. was founded in 2002 and is based in Shenzhen, China.

Recent 688617 News & Updates

Recent updates

No updates